| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Diagnostics | $441.5M | $387.4M | $359.5M | $427.5M | $482.8M | $450.4M | $419.2M | $458.7M |
| Biopharma Laboratory Services | — | — | — | $106.9M | $123.3M | $132.2M | $136.1M | $120.7M |
| Corporate Segment | -$180.3M | -$172.5M | -$189.1M | -$132.4M | -$139.2M | -$109.9M | -$100.7M | -$116.6M |
| Total | $294.8M | $254.1M | $216.5M | $326M | $394.5M | $396.6M | $267.6M | $380.8M |